March 24, 2020 / 10:03 PM / 4 days ago

BRIEF-Onconova Therapeutics Announces Completion Of Enrollment Of Phase 3 Inspire Trial

March 24 (Reuters) - Onconova Therapeutics Inc:

* ONCONOVA THERAPEUTICS ANNOUNCES COMPLETION OF ENROLLMENT OF PHASE 3 INSPIRE TRIAL, PROVIDES A CORPORATE UPDATE, AND REPORTS 2019 FINANCIAL RESULTS

* ONCONOVA THERAPEUTICS- ANTICIPATE REPORTING TOPLINE SURVIVAL DATA IN SECOND HALF OF 2020 AND PRESENTING RESULTS AT A MEDICAL MEETING LATER THIS YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below